Literature DB >> 3968497

Menstrual cycle and exposure to oestrogens unopposed by progesterone: relevance to studies on breast cancer incidence.

M G Metcalf, J A Mackenzie.   

Abstract

It is claimed that the exposure of women to oestrogens unopposed by progesterone increases the risk of breast cancer. Despite indirect evidence in support of this claim, the impracticability of monitoring oestrogen and progesterone levels in large numbers of women for prolonged periods of time has meant that no direct demonstration of the effect has been made. A possible technique is suggested. The ratio (R) of oestrogens to pregnanediol in urine has been used as an index of oestrogen exposure relative to progesterone. Samples were collected at weekly intervals on 700 occasions from 30 perimenopausal women, and on 519 occasions from 66 women with a history of regular menstrual cyclicity. Unusually prolonged episodes of unopposed high oestrogen excretion (R greater than or equal to 100 for greater than or equal to 2 successive weeks) were observed on 30 occasions in 15 of the perimenopausal women and on four occasions in the other women. In the perimenopausal group, these episodes occurred in 46.9% of the 32 menstrual cycles which were longer than 50 days compared with 6.9% of the 72 cycles which were shorter than 35 days (P less than 0.001). The association of prolonged episodes of unopposed high oestrogen excretion with long menstrual cycles suggests the possibility of using menstrual cycle length as an index of oestrogen exposure during the menopausal transition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968497     DOI: 10.1677/joe.0.1040137

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

Review 1.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 2.  The menopause and aging, a comparative perspective.

Authors:  Caleb E Finch
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-10       Impact factor: 4.292

3.  Total and unopposed estrogen exposure across stages of the transition to menopause.

Authors:  Kathleen A O'Connor; Rebecca J Ferrell; Eleanor Brindle; Jane Shofer; Darryl J Holman; Rebecca C Miller; Deborah E Schechter; Burton Singer; Maxine Weinstein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

4.  Regularity and length of menstrual cycles in women aged 41-46 in relation to breast cancer risk: results from the DOM-project.

Authors:  I den Tonkelaar; F de Waard
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Progesterone for Symptomatic Perimenopause Treatment - Progesterone politics, physiology and potential for perimenopause.

Authors:  J C Prior
Journal:  Facts Views Vis Obgyn       Date:  2011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.